Estados financieros detallados de Bionano Genomics, Inc. (BNGO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Bionano Genomics, Inc. registró ingresos de $28.5M en el último ejercicio fiscal, con un CAGR de 5 años del 27.4%.
Márgenes de los últimos 12 meses: margen bruto 47.5%, margen operativo -106.7%, margen neto -106.6%.
Al precio actual de $1.51, BNGO presenta beneficios negativos (P/E no significativo) y un ROE del -78.78%. La capitalización bursátil es de $17M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $6.8M | $9.5M | $12.0M | $10.1M | $8.5M | $18.0M | $27.8M | $36.1M | $30.8M | $28.5M |
| Coste de Ventas | $3.6M | $6.0M | $8.7M | $6.8M | $5.7M | $14.1M | $21.9M | $26.6M | $30.4M | $22.2M |
| Beneficio Bruto | $3.2M | $3.5M | $3.3M | $3.4M | $2.8M | $3.9M | $5.9M | $9.6M | $380000 | $6.3M |
| I+D | $11.4M | $12.0M | $9.5M | $9.1M | $10.3M | $22.5M | $49.0M | $54.0M | $24.8M | $11.4M |
| Generales y Administrativos | $13.0M | $14.1M | $14.2M | $20.2M | 0 | $58.5M | $88.6M | $95.0M | $51.9M | $28.2M |
| Gastos Operativos | $24.4M | $26.1M | $23.7M | $29.2M | $41.3M | $81.0M | $137.6M | $224.8M | $104.4M | $39.6M |
| Beneficio Operativo | -$21.2M | -$23.2M | -$20.4M | -$25.9M | -$38.6M | -$77.1M | -$131.7M | -$215.2M | -$104.0M | -$33.3M |
| EBITDA | -$17.3M | -$21.3M | -$15.8M | -$26.4M | -$35.6M | -$73.9M | -$120.3M | -$213.6M | -$97.5M | -$16.3M |
| Gastos por Intereses | $470072 | $590927 | $1.4M | $2.3M | $2.5M | $927000 | $298000 | $5.1M | $289000 | $298000 |
| Beneficio Antes de Impuestos | -$18.8M | -$23.3M | -$18.5M | -$29.8M | -$41.1M | -$78.2M | -$130.7M | -$232.4M | -$112.0M | -$26.3M |
| Impuestos | $12924 | $18552 | $15511 | $21048 | $29000 | -$5.7M | $1.9M | $62000 | $33000 | $67000 |
| Beneficio Neto | -$18.8M | -$23.4M | -$18.5M | -$29.8M | -$41.1M | -$72.4M | -$132.6M | -$232.5M | -$112.0M | -$26.4M |
| BPA | $-1131.43 | $-1402.56 | $-1568.13 | $-1194.36 | $-236.58 | $-157.02 | $-275.09 | $-408.48 | $-88.13 | $-4.85 |
| BPA Diluido | $-1131.43 | $-1402.56 | $-1568.13 | $-1194.36 | $-236.58 | $-157.02 | $-275.09 | $-408.48 | $-88.13 | $-4.85 |
| Acciones en Circulación (Diluidas) | $16659 | $16659 | $11795 | $24963 | $173752 | $461303 | $482016 | $569166 | $1.3M | $5.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $7.4M | $8.0M | $6.7M | $8.2M |
| Beneficio Bruto | $3.4M | $3.4M | $3.3M | $4.3M |
| Beneficio Operativo | -$8.5M | -$8.5M | -$7.9M | -$7.2M |
| EBITDA | -$6.0M | -$5.4M | -$5.9M | -$5.1M |
| Beneficio Neto | -$8.5M | -$7.9M | -$8.3M | -$7.4M |
| BPA | $-1.59 | $-0.74 | $-0.76 | $-0.64 |
| BPA Diluido | $-1.59 | $-0.74 | $-0.76 | $-0.64 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $5.2M | $1.0M | $16.5M | $17.3M | $38.4M | $24.6M | $5.1M | $17.9M | $9.2M | $3.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $226.0M | $108.1M | $48.8M | $302000 | $10.3M |
| Cuentas por Cobrar | $1.8M | $3.4M | $4.5M | $6.3M | $2.8M | $5.3M | $7.5M | $9.7M | $4.8M | $5.2M |
| Inventario | $1.8M | $1.7M | $1.1M | $3.4M | $3.3M | $12.4M | $29.8M | $22.9M | $11.1M | $5.4M |
| Activos Corrientes | $10.7M | $7.1M | $23.0M | $28.3M | $46.8M | $272.4M | $157.3M | $140.1M | $39.5M | $45.4M |
| Inmovilizado Material | $4.1M | $3.0M | $1.8M | $1.9M | $4.9M | $20.9M | $29.0M | $32.5M | $24.3M | $21.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | $7.2M | $56.2M | $77.3M | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $1.5M | $26.8M | $41.1M | $34.0M | $9.7M | $4.3M |
| Activos Totales | $14.8M | $10.1M | $24.8M | $30.2M | $60.5M | $377.1M | $307.5M | $214.4M | $76.7M | $73.6M |
| Cuentas por Pagar | $792332 | $2.3M | $1.4M | $2.7M | $2.9M | $10.8M | $12.5M | $10.4M | $7.0M | $5.6M |
| Deuda a Corto | $587131 | $6.7M | 0 | $20.1M | 0 | 0 | 0 | $69.8M | $20.4M | 0 |
| Pasivos Corrientes | $9.4M | $16.7M | $4.5M | $26.4M | $8.9M | $21.8M | $35.9M | $100.0M | $37.3M | $22.9M |
| Deuda a Largo | $6.0M | 0 | $9.0M | 0 | $16.3M | 0 | 0 | 0 | 0 | $6.0M |
| Pasivos Totales | $42.0M | $60.4M | $14.7M | $26.6M | $25.4M | $40.0M | $58.1M | $118.2M | $41.3M | $29.2M |
| Reservas | -$30.9M | -$54.3M | -$72.8M | -$102.6M | -$143.7M | -$216.1M | -$348.7M | -$581.2M | -$693.2M | -$719.6M |
| Patrimonio Neto | -$27.3M | -$50.2M | $10.1M | $3.6M | $35.1M | $337.1M | $249.4M | $96.2M | $35.4M | $44.4M |
| Deuda Total | $6.6M | $6.7M | $9.0M | $20.1M | $16.3M | $10.7M | $11.7M | $79.4M | $27.3M | $6.9M |
| Deuda Neta | $1.4M | $5.7M | -$7.5M | $2.8M | -$22.1M | -$239.9M | -$101.5M | $12.6M | $17.8M | -$6.3M |
| Capital Circulante | $1.4M | -$9.5M | $18.5M | $1.9M | $37.8M | $250.6M | $121.4M | $40.1M | $2.1M | $22.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $3.1M | $3.0M | $13.7M | $3.7M |
| Activos Totales | $79.1M | $73.6M | $64.8M | $47.6M |
| Pasivos Totales | $29.3M | $29.2M | $27.3M | $16.0M |
| Patrimonio Neto | $49.8M | $44.4M | $37.5M | $31.6M |
| Deuda Total | $17.2M | $6.9M | $17.0M | $6.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$18.8M | -$23.4M | -$18.5M | -$29.8M | -$41.1M | -$72.4M | -$132.6M | -$232.5M | -$112.0M | -$26.4M |
| Amortizaciones | $1.1M | $1.5M | $1.3M | $1.1M | $1.5M | $3.4M | $9.8M | $13.9M | $14.2M | $9.7M |
| Compensación en Acciones | $130643 | $382830 | $1.3M | $1.3M | $1.6M | $9.7M | $22.4M | $15.2M | $9.7M | $4.5M |
| Cambio en Capital Circulante | -$3.0M | $85103 | -$2.4M | -$5.0M | -$3.4M | -$7.7M | -$27.9M | -$14.8M | $4.4M | $514000 |
| Flujo de Caja Operativo | -$23.5M | -$20.8M | -$19.9M | -$29.5M | -$38.3M | -$71.9M | -$124.8M | -$125.2M | -$68.9M | -$16.3M |
| Inversiones (CapEx) | -$1.3M | -$1.0M | -$331716 | -$61056 | 0 | -$1.5M | -$3.3M | -$1.7M | -$103000 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | -$2.5M | -$49.1M | -$31.3M | $96000 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$24.8M | -$21.8M | -$20.3M | -$29.6M | -$38.3M | -$73.4M | -$128.1M | -$126.9M | -$69.0M | -$16.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.9M | -$4.2M | -$5.7M | -$4.7M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.9M | -$4.2M | -$5.7M | -$4.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $941000 | $926000 | $670000 | $970000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +39.9% | +26.3% | -15.6% | -16.1% | +111.5% | +54.6% | +29.9% | -14.8% | -7.4% |
| Crecimiento Beneficio Neto (anual) | | -24.0% | +20.8% | -61.2% | -37.9% | -76.2% | -83.1% | -75.3% | +51.8% | +76.4% |
| Crecimiento BPA (anual) | | -24.0% | -11.8% | +23.8% | +80.2% | +33.6% | -75.2% | -48.5% | +78.4% | +94.5% |
| Cambio en Acciones (anual) | | +0.0% | -29.2% | +111.6% | +596.0% | +165.5% | +4.5% | +18.1% | +123.3% | +328.4% |
| Crecimiento FCF (anual) | | +12.1% | +7.1% | -45.9% | -29.5% | -91.5% | -74.6% | +1.0% | +45.6% | +76.3% |
| Margen Bruto | 47.3% | 36.6% | 27.4% | 33.2% | 32.6% | 21.5% | 21.4% | 26.5% | 1.2% | 22.0% |
| Margen Operativo | -311.6% | -244.3% | -170.1% | -255.4% | -453.4% | -428.8% | -473.7% | -596.0% | -337.9% | -116.9% |
| Margen EBITDA | -254.0% | -223.6% | -131.5% | -260.4% | -418.3% | -410.7% | -432.8% | -591.4% | -316.7% | -57.2% |
| Margen Neto | -277.5% | -245.8% | -154.1% | -294.3% | -483.4% | -402.8% | -476.9% | -643.7% | -364.0% | -92.6% |
| Margen FCF | -365.8% | -229.7% | -169.0% | -292.1% | -450.6% | -408.1% | -460.8% | -351.3% | -224.3% | -57.3% |
| Tasa Impositiva Efectiva | -0.1% | -0.1% | -0.1% | -0.1% | -0.1% | 7.3% | -1.4% | -0.0% | -0.0% | -0.3% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-1491.46 | $-1310.74 | $-1719.00 | $-1185.39 | $-220.51 | $-159.09 | $-265.80 | $-222.91 | $-54.31 | $-3.00 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $16659 | $16659 | $11795 | $24963 | $173752 | $461303 | $482016 | $569166 | $1.3M | $5.4M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -78.78% |
| Rentabilidad sobre capital invertido | -83.76% |
| Rentabilidad sobre activos | -67.58% |
| Margen bruto | 47.50% |
| Margen operativo | -106.67% |
| Margen neto | -106.58% |
Salud financiera
| Deuda / Patrimonio | 0.21 |
| Ratio corriente | 2.48 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -14.26 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -3.26 | -2.63 | -2.00 | -0.62 | -7.81 | -11.43 | -3.18 | -0.28 | -0.20 | -0.32 |
| P/VC | -2.26 | -1.22 | 3.66 | 5.14 | 9.15 | 2.45 | 1.69 | 0.67 | 0.62 | 0.19 |
| P/V | 9.05 | 6.47 | 3.09 | 1.83 | 37.76 | 46.03 | 15.19 | 1.79 | 0.71 | 0.29 |
| Margen Bruto | 47.3% | 36.6% | 27.4% | 33.2% | 32.6% | 21.5% | 21.4% | 26.5% | 1.2% | 22.0% |
| Margen Operativo | -311.6% | -244.3% | -170.1% | -255.4% | -453.4% | -428.8% | -473.7% | -596.0% | -337.9% | -116.9% |
| Margen Neto | -277.5% | -245.8% | -154.1% | -294.3% | -483.4% | -402.8% | -476.9% | -643.7% | -364.0% | -92.6% |